Septicemia mortality reduction in neonates in a heart rate characteristics monitoring trial
Karen D Fairchild, Robert L Schelonka, David A Kaufman, Waldemar A Carlo, John Kattwinkel, Peter J Porcelli, Cristina T Navarrete, Eduardo Bancalari, Judy L Aschner, M Whit Walker, Jose A Perez, Charles Palmer, Douglas E Lake, T Michael O'Shea, J Randall Moorman, Karen D Fairchild, Robert L Schelonka, David A Kaufman, Waldemar A Carlo, John Kattwinkel, Peter J Porcelli, Cristina T Navarrete, Eduardo Bancalari, Judy L Aschner, M Whit Walker, Jose A Perez, Charles Palmer, Douglas E Lake, T Michael O'Shea, J Randall Moorman
Abstract
Background: Abnormal heart rate characteristics (HRC) wax and wane in early stages of culture-positive, late-onset septicemia (LOS) in patients in the neonatal intensive care unit (NICU). Continuously monitoring an HRC index leads to a reduction in mortality among very low birth weight (VLBW) infants. We hypothesized that the reduction in mortality was due to a decrease in septicemia-associated mortality.
Methods: This is a secondary analysis of clinical and HRC data from 2,989 VLBW infants enrolled in a randomized clinical trial of HRC monitoring in nine NICUs from 2004 to 2010.
Results: LOS was diagnosed 974 times in 700 patients, and the incidence and distribution of organisms were similar in HRC display and nondisplay groups. Mortality within 30 d of LOS was lower in the HRC display as compared with the nondisplay group (11.8 vs. 19.6%; relative risk: 0.61; 95% confidence interval: 0.43, 0.87; P < 0.01), but mortality reduction was not statistically significant for patients without LOS. There were fewer large, abrupt increases in the HRC index in the days leading up to LOS diagnosis in infants whose HRC index was displayed.
Conclusion: Continuous HRC monitoring is associated with a lower septicemia-associated mortality in VLBW infants, possibly due to diagnosis earlier in the course of illness.
Conflict of interest statement
DISCLOSURES: J.R.M. and D.E.L. have consulting agreements and equity shares in Medical Predictive Science Corporation, Charlottesville, VA. The other authors declare no conflicts of interest.
Figures
References
- Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–291.
- Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey. Clin Infect Dis. 2005;40:218–224.
- Schlapbach LJ, Aebischer M, Adams M, et al. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics. 2011;128:e348–e357.
- Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357–2365.
- Raynor LL, Saucerman JJ, Akinola MO, Lake DE, Moorman JR, Fairchild KD. Cytokine screening identifies NICU patients with Gram-negative bacteremia. Pediatr Res. 2012;71:261–266.
- Ng PC, Ang IL, Chiu RW, et al. Host-response biomarkers for diagnosis of lateonset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest. 2010;120:2989–3000.
- Brocklehurst P, Farrell B, King A, et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med. 2011;365:1201–1211.
- Carr R, Modi N, Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev. 2003:CD003066.
- Fairchild KD, O'Shea TM. Heart rate characteristics: physiomarkers for detection of late-onset neonatal sepsis. Clin Perinatol. 2010;37:581–598.
- Fairchild K, Aschner JL. HeRO monitoring to reduce mortality in NICU patients. Research and Reports in Neonatology. 2012;2:65–76.
- Griffin MP, Lake DE, Bissonette EA, Harrell FE, Jr, O'Shea TM, Moorman JR. Heart rate characteristics: novel physiomarkers to predict neonatal infection and death. Pediatrics. 2005;116:1070–1074.
- Griffin MP, O'Shea TM, Bissonette EA, Harrell FE, Jr, Lake DE, Moorman JR. Abnormal heart rate characteristics preceding neonatal sepsis and sepsis-like illness. Pediatr Res. 2003;53:920–926.
- Moorman JR, Lake DE, Griffin MP. Heart rate characteristics monitoring for neonatal sepsis. IEEE Trans Biomed Eng. 2006;53:126–132.
- Griffin MP, Scollan DF, Moorman JR. The dynamic range of neonatal heart rate variability. Journal of Cardiovascular Electrophysiology. 1994;5:112–124.
- Cao H, Lake DE, Griffin MP, Moorman JR. Increased nonstationarity of neonatal heart rate before the clinical diagnosis of sepsis. Ann Biomed Eng. 2004;32:233–244.
- Kovatchev BP, Farhy LS, Cao H, Griffin MP, Lake DE, Moorman JR. Sample asymmetry analysis of heart rate characteristics with application to neonatal sepsis and systemic inflammatory response syndrome. Pediatr Res. 2003;54:892–898.
- Lake DE, Richman JS, Griffin MP, Moorman JR. Sample entropy analysis of neonatal heart rate variability. Am J Physiol Regul Integr Comp Physiol. 2002;283:R789–R797.
- Moorman JR, Carlo WA, Kattwinkel J, et al. Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J Pediatr. 2011;159:900–906. e1.
- Griffin MP, Moorman JR. Toward the early diagnosis of neonatal sepsis and sepsis-like illness using novel heart rate analysis. Pediatrics. 2001;107:97–104.
- Griffin MP, Lake DE, Moorman JR. Heart rate characteristics and laboratory tests in neonatal sepsis. Pediatrics. 2005;115:937–941.
- Griffin MP, Lake DE, O'Shea TM, Moorman JR. Heart rate characteristics and clinical signs in neonatal sepsis. Pediatr Res. 2007;61:222–227.
- Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression and survival analysis. Berlin: Springer; 2001.
Source: PubMed